| HOME >> MEDICINE >> TECHNOLOGY |
Figure 35: Pharmaceutical & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 58
Figure 36: Pharmaceutical & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 60
Figure 37: Pharmaceutical & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 62
Figure 38: Pharmaceutical & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 64
Figure 39: Pharmaceutical & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 66
Figure 40: Pharmaceutical & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 68
Figure 41: Pharmaceutical & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 70
Figure 42: Pharmaceutical & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 72
Figure 43: Pharmaceutical & Healthcare, Global, Musculoskeletal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 74
Figure 44: Pharmaceutical & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 76
Figure 45: Pharmaceutical & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 78
Figure 46: Pharmaceutical & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 80
Figure 47: Pharmaceutical & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q2 2010 - Q2 2011 82
Figure 48: Pharmaceutical & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q3 2010 - Q2 2011 84
Figure 49: Pharmaceutical &
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |